title: Infections and organ transplantation: new challenges for prevention and treatment of hepatitis C virus.
abstract: Hepatitis C virus infection is a widespread condition, affecting about 170 million people worldwide. It is associated with the progression to cirrhosis, hepatic decompensation, and hepatocellular carcinoma. Therefore, antiviral treatment appears to be recommended for patients infected with HCV. This article reviewed recent evidence on antiviral therapy for HCV-infected patients.
authors.affiliation: Multivisceral Transplant Unit, Gastroenterology, Padova University, Padova Italy. burra@unipd.it
authors.forename: P
authors.initials: P
authors.lastname: Burra
authors.forename: E
authors.initials: E
authors.lastname: De Martin
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000175:diagnosis / Q000601:surgery* / Q000821:virology; D006526:Hepatitis C / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control; D006801:Humans; D008103:Liver Cirrhosis / Q000175:diagnosis / Q000601:surgery* / Q000821:virology; D008113:Liver Neoplasms / Q000175:diagnosis / Q000601:surgery* / Q000821:virology; D016031:Liver Transplantation / Q000009:adverse effects; D055502:Secondary Prevention; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents